Remove Biotech Remove Innovation Remove Sustainability
article thumbnail

The Week’s Biggest Funding Rounds: Data Storage And Lots Of Biotech

Crunchbase News

Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. The company plans to use the new cash to expand in industries ranging from healthcare to autonomous vehicles and accelerate product innovation, including for its AI data intelligence platform.

Biotech 120
article thumbnail

5 ways biotech startups can mitigate risk to grow sustainably in the long run

TechCrunch

Capital is the fuel that advances scientific and technological innovation, and it means a life science startup can create products that benefit the world at large. In the world of biotech, for example, it’s extremely capital intensive to develop multiple products that are all going through clinical trials simultaneously.

Biotech 242
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Deep tech disruption: How advanced technologies are transforming businesses

CIO

CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. CRISPR) for personalized medicine and drought-resistant crops.

article thumbnail

Techstars unveils sustainability-focused acceleration program in Paris

TechCrunch

Techstars , a network of startup accelerators and an investment company, is launching a new accelerator in Paris called Techstars Sustainability Paris. With this sustainability-focused accelerator, Techstars is hitting the reboot button. Every year, Techstars Sustainability Paris plans to accept 24 startups across two batches.

article thumbnail

Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19

TechCrunch

COVID-19 has exposed critical vulnerabilities in medical supply chains, and today’s manufacturing can’t keep up with scientific innovation, medical discovery, and the need to rapidly produce and distribute critically important drugs at scale. billion to spend on sustainability and health-focused biotech. “It

article thumbnail

With a €43M EU grant and €1.2M from a VC, this startup plans to turn CO2 emissions into gold

TechCrunch

It’s hoped that if carbon dioxide could be converted at the point of emission, we could deal with the climate crisis a lot faster and create a sustainable carbon economy. Now Copenhagen-based biotech company SecondCircle thinks it also has a novel approach. There are a few companies trying to tackle this. It has raised $310.4

Chemicals 241
article thumbnail

How Rani Therapeutics’ robotic pill could change subcutaneous injection treatment

TechCrunch

A prominent figure in life sciences innovation, Imran has founded over 20 medical device companies and helped develop the world’s first implantable cardiac defibrillator. In January 2020, their acromegaly treatment, Octreotide, demonstrated both safety and sustained bioavailability in primary clinical trials.

Biotech 252